logo
Top Stories
56
45
tesla-052119-lg.jpg

Morgan Stanley has cut its worst-case forecast on Tesla Inc.'s (TSLA) share price from the previous estimate of $97 to just $10, dealing another blow to the luxury electric car maker. The worst-case or "bear case" scenario by Morgan Stanley analysts...

preview-may22-lg.jpg

Consumer and producer prices and public sector finance reports from the UK are due on Wednesday, headlining a light day for the European economic news. At 3.00 am ET, European Central Bank President Mario Draghi is set to speak at an event organized...

donmcgahn-052119-lg.jpg

For the second time in less than a month, a senior member of President Donald Trump's administration defied a subpoena to appear before the House Judiciary Committee on Tuesday. Former White House Counsel Don McGahn joined Attorney General William...

stockmarkets-dec12_22may19-lg.jpg

European stocks were trading mixed on Wednesday as global trade tensions mounted and investors looked ahead to the release of FOMC meeting minutes for direction. Investors fretted about a protracted U.S.-China trade war after the New York Times reported...

microsoftbuilds-may14.jpg Technology giant Microsoft is working on a decentralized identity or DID network on top of the bitcoin blockchain. In a blog post, the company announced an early preview of a Sidetree-based DID network, called Identity Overlay Network or ION. The infrastructure atop the bitcoin blockchain is based on an emerging set of open standards developed with partners in the Decentralized Identity Foundation
bitwisefiles-jan11_15may19.jpg The United States Securities and Exchange Commission has again delayed taking a decision on bitcoin exchange-traded fund or ETF application by Bitwise Asset Management. The regulator requested public comments to determine whether to approve or disapprove the proposed rule change related to the listing and trading of shares of the bitcoin ETF, as modified by amendment on May 7.
wallstreet-may15.jpg Retails Sales and Industrial Production reports for April are the important economic announcements on Wednesday. Investors continue to have an eye on the developments related to U.S.- China trade talks. Early cues from the U.S. Futures Index is...
wallstreet-aug31_15may19.jpg Stocks may come under pressure in early trading on Wednesday, moving back to the downside following the rebound seen in the previous session. The major index futures are currently pointing to a lower open for the markets, with the Dow futures down by 145 points.
Read More
trump-immigrants-052019.jpg President Donald Trump refuted reports of proposed mass transfer of migrants from the southern border to northern or coastal border facilities, including in Florida, to lessen the workload at crowded Border Patrol facilities. "False reporting yesterday. There are no plans to send migrants to Northern or Coastal Border facilities, including Florida," Trump said on Twitter Sunday, naming Fox News.
Read More
donmcgahn-052119.jpg For the second time in less than a month, a senior member of President Donald Trump's administration defied a subpoena to appear before the House Judiciary Committee on Tuesday. Former White House Counsel Don McGahn joined Attorney General William Barr in refusing to testify before the important House committee.
Read More
aspirin-may14.jpg
The benefits of daily aspirin in patients with established cardiovascular disease outweigh the risks. There is no question about it. But the role of low-dose aspirin in the primary prevention of cardiovascular disease, i.e. for lower-risk people without a history of heart disease, has long been debated.
Read More
U.K. stocks advanced on Wednesday and the pound extended a negative trend after British Prime Minister Theresa May set out what she called a "new" Brexit deal for Britain's departure from the EU. The deal offers the option of a parliamentary vote on holding a second referendum on her deal if it clears...
tesla-052119.jpg
Morgan Stanley has cut its worst-case forecast on Tesla Inc.'s share price from the previous estimate of $97 to just $10, dealing another blow to the luxury electric car maker. The worst-case or "bear case" scenario by Morgan Stanley analysts takes into account the risk posed if Tesla misses its current sales outlook for China by about half.
Read More
ABN AMRO is among other commodity industry players and financial institutions that are exploring options to launch digital blockchain platform Forcefield, which will help track trade inventories in real-time.The other firms that have until now signed a MOU to launch Forcefield are Accenture, Anglo American, CMST International, Hartree Partners, ING Bank, Macquarie, Mercuria and OCBC Bank. Read More
A lot happened in the month of April, from the resignation of FDA Commissioner Scott Gottlieb coming into effect to the launch of the world's first malaria vaccine. Now, let's take a look at the companies that await a ruling from the FDA in May 2019. Read More
The following are some of today's top gainers in the pharma/biotech sector. Read More
abnamro-052119.jpg ABN AMRO is among other commodity industry players and financial institutions that are exploring options to launch digital blockchain platform Forcefield, which will help track trade inventories in real-time.The other firms that have until now signed a MOU to launch Forcefield are Accenture, Anglo American, CMST International, Hartree Partners, ING Bank, Macquarie, Mercuria and OCBC Bank.
Read More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
05/22/19 6:0PPI (Y-o-Y)APR Ireland
05/22/19 6:0PPI (M-o-M)APR Ireland
05/22/19 6:0Unemployment RateQ1 Latvia
05/22/19 5:0Wage Cost Index (Y-o-Y)APR Iceland
05/22/19 5:0Wage Cost Index (M-o-M)APR Iceland
05/22/19 4:55Interest Rate Decision- Iceland
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
08/19/19NBRVLefamulin (NDA) FDA decision on oral and IV formulations of Lefamulin for bacterial pneumonia
08/16/19VNDAHETLIOZ (sNDA)FDA decision on HETLIOZ for the expanded indication of jet lag disorder
08/03/19DSKYF.PKPexidartinib (NDA)FDA decision on Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor
07/06/19KPTISelinexor (NDA)FDA decision on Selinexor for patients with refractory multiple myeloma
06/30/19DOVADOPTELET (sNDA)FDA decision on DOPTELET for chronic immune thrombocytopenia
View All